During the past decade, San Juan Hospital, Research Unit conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "San Juan Hospital, Research Unit" #1 sponsor was "Eli Lilly and Company" with 1 trials, followed by "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "SCRI Development Innovations, LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "San Juan Hospital, Research Unit" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "Walter Reed Army Institute of Research (WRAIR)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "San Juan Hospital, Research Unit" are "Breast Cancer" (1 trials), "Chikungunya Virus Infection" (1 trials), "Disease Transmission, Vertical" (1 trials), "Flaviviral Diseases" (1 trials) and "Flaviviridae Infections" (1 trials). Many other conditions were trialed in "San Juan Hospital, Research Unit" in a lesser frequency.

Most popular intervention types in "San Juan Hospital, Research Unit" are "Biological" (3 trials), "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials), "Cyclophosphamide" (1 trials), "Doxorubicin" (1 trials) and "Dulaglutide" (1 trials). Other intervention names were less common.

The vast majority of trials in "San Juan Hospital, Research Unit" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "San Juan Hospital, Research Unit". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in San Juan Hospital, Research Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in San Juan Hospital, Research Unit, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".